<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04789005</url>
  </required_header>
  <id_info>
    <org_study_id>439/(6-11)E²/076/077</org_study_id>
    <nct_id>NCT04789005</nct_id>
  </id_info>
  <brief_title>Comparison of Phenylephrine and Norepinephrine for Spinal-induced Hypotension</brief_title>
  <official_title>Comparison of Intravenous Phenylephrine and Norepinephrine for Treatment of Spinal-induced Hypotension in Caesarian Deliveries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tribhuvan University Teaching Hospital, Institute Of Medicine.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tribhuvan University Teaching Hospital, Institute Of Medicine.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypotension after spinal anaesthesia for cesarean deliveries is frequently encountered.&#xD;
      Phenylephrine an α-agonist is commonly used for the prevention and treatment of&#xD;
      spinal-induced hypotension. Phenylephrine causes baroreceptor-mediated bradycardia leading to&#xD;
      subsequent reduction in cardiac output. Preservation of heart rate and cardiac output is&#xD;
      important in high-risk conditions such as placental insufficiency, fetal distress and&#xD;
      maternal cardiac disease. Recently, norepinephrine has been found as effective as&#xD;
      phenylephrine in treatment of spinal induced hypotension. When norepinephrine is used as a&#xD;
      bolus, it is effective at maintaining blood pressure while also conferring a greater heart&#xD;
      rate and cardiac output compared to phenylephrine.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 10, 2019</start_date>
  <completion_date type="Actual">May 5, 2020</completion_date>
  <primary_completion_date type="Actual">May 5, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare blood pressure between two groups.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>To compare percentage of incidence of hypotension between two groups.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>compare percentage of incidence of bradycardia between the two groups</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Spinal Induced-hypotension</condition>
  <arm_group>
    <arm_group_label>Phenylephrine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Phenylephrine 100mcg was administered manually by the anaesthesiologist every time the SBP was 20% lower than baseline and the HR ≥60 bpm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Norepinephrine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Norepinephrine 8mcg was administered manually by the anaesthesiologist every time the SBP was 20% lower than baseline and the HR ≥60 bpm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norepinephrine</intervention_name>
    <description>Norepinephrine 8mcg was administered manually by the anaesthesiologist every time the SBP was 20% lower than baseline and the HR ≥60 bpm.</description>
    <arm_group_label>Norepinephrine group</arm_group_label>
    <other_name>Norepinephrine group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenylephrine</intervention_name>
    <description>Phenylephrine 100mcg was administered manually by the anaesthesiologist every time the SBP was 20% lower than baseline and the HR ≥60 bpm.</description>
    <arm_group_label>Phenylephrine group</arm_group_label>
    <other_name>Phenylepherine group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Elective cesarean delivery under spinal anaesthesia ASA PS II Age ≥18 years Singleton&#xD;
        pregnancy beyond 37 weeks' gestation Weight between 50 and 100 kg Height between 150 and&#xD;
        180 cm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patient refusal to participate Allergy or hypersensitivity to Norepinephrine or&#xD;
        Phenylephrine Preexisting or pregnancy-induced hypertension Cardiovascular or&#xD;
        cerebrovascular disease Fetal abnormalities Use of monoamine oxidase inhibitors or&#xD;
        tricyclic antidepressants&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tribhuvan university teaching hospital</name>
      <address>
        <city>Kathmandu</city>
        <state>Bagmati</state>
        <zip>00977</zip>
        <country>Nepal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nepal</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 10, 2021</study_first_submitted>
  <study_first_submitted_qc>March 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tribhuvan University Teaching Hospital, Institute Of Medicine.</investigator_affiliation>
    <investigator_full_name>ALLEN SUWAL</investigator_full_name>
    <investigator_title>Resident Anaesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
    <mesh_term>Norepinephrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

